Lithium Carbonate shortage — TH supply status & alternatives

Lithium Carbonate

—

🇦🇺 AUST R 49625 · Aspen Pharmacare Australia Pty Ltd

In supply · Australia

WHO Essential Medicine

Apo-Lithium Carbonate

In supply · 🇦🇺 Australia · short in🇫🇷 FR🇨🇦 CA🌐 TH

In supply in Australia

Reading today’s signals…

🇦🇺 AUAEMPA$31.46DPMQ A$79.98details →

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

Product attributes reference data we hold

Active ingredient (INN)	Lithium Carbonate
Brand names	Apo-Lithium Carbonate
Therapeutic category	Auto-created by Health Canada — Drug Shortages Database scraper
WHO Essential Medicine	Yes (2023)
Controlled substance	No
Marketing-authorisation holders	Essential Pharma Limited, HIKMA PHARMACEUTICALS USA INC., Aspen Pharmacare Australia Pty Ltd
Registrations on file	9
Patient information leaflet (PIL)	Not on file
Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 PBS · July 2026

🇦🇺 AU

● Official price on file

Ex-manufacturer

A$31.46

AEMP

Dispensed (DPMQ)

A$79.98

incl. fees

Pack

lithium carbonate 450 mg modified release tablet, 100

Source: PBSEffective July 2026 · AUD

Other markets

🇺🇸 US

US$0.20

Acquisition

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

11 API manufacturers

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

Low concentration risk

Maithri Drugs Private LTDAlbemarle CorpSun Pharmaceutical Industries LTDLivent USA CorpLek Pharmaceuticals DdEuticals SPA+5 more

Manufacturing countries: India, United States, China · Source: FDA List of Drug Master Files

Verified timeline regulator events

🇫🇷 22 Apr 2026

medium reported

🇫🇷 14 Apr 2026

Shortage resolved

🇫🇷 5 Mar 2026

medium reported

🇫🇷 9 Feb 2026

high reported

🇫🇷 29 Oct 2025

medium reported

🇨🇦 4 Feb 2025

medium reported

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders9 registrations · 3 MA holders

Product	Strength	Form	Market	MA holder	Status
Lithium Carbonate Essential Pharma	250 MG	tablet	🇬🇧 GB	Essential Pharma Limited	Active
Camcolit	400 MG	camcolit	🇬🇧 GB	Essential Pharma Limited	Active
Lithium Carbonate	450mg/1	tablet	🇺🇸 US	HIKMA PHARMACEUTICALS USA INC.	Active
Lithium Carbonate	300mg/1	tablet	🇺🇸 US	HIKMA PHARMACEUTICALS USA INC.	Active
Lithium Carbonate	150mg/1	capsule	🇺🇸 US	HIKMA PHARMACEUTICALS USA INC.	Active
Lithium Carbonate	600mg/1	capsule	🇺🇸 US	HIKMA PHARMACEUTICALS USA INC.	Active
LITHICARB lithium carbonate	250mg	—	🇦🇺 AU	Aspen Pharmacare Australia Pty Ltd	Active
Lithicarb Sr	400mg	tabmr	🇦🇺 AU	Aspen Pharmacare Australia Pty Ltd	Active
QUILONUM SR lithium carbonate	450mg	—	🇦🇺 AU	Aspen Pharmacare Australia Pty Ltd	Active

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.